The bioavailability of two new preparations of spironolactone tablets
- 49 Downloads
Two new preparations of spironolactone tablets containing 25 and 100 mg of spironolactone have been characterized by their disintegration time, tablet spironolactone content, dissolution profile and bioavailability in comparison with two known spironolactone preparations as reference material. The preparations were found to possess almost identical characteristics, assuring a proper clinical use of the new tablet preparations. For spironolactone, a positive outcome of thein vitro dissolution test coincides with an excellent bioavailability.
KeywordsPublic Health Internal Medicine Assure Positive Outcome Reference Material
Unable to display preview. Download preview PDF.
- Gochman, N., andC.L. Gantt (1962)J. Pharmacol. Exp. Ther. 135, 313–316.Google Scholar
- Melander, A. (1983) In:Handbook of Clinical Pharmacokinetics (Gibaldi, M., andL. Prescott, Eds.). Adis Press, New York, Section 1, 39–54.Google Scholar
- Poole, J.W. (1969)Drug Inf. Bull. 3, 8–16.Google Scholar
- Sadée, W., andG.C.M. Beelen (1980)Drug Level Monitoring. John Wiley & Sons, New York, 423–426.Google Scholar